BSE's Closing Auction Session Creates Self-Reinforcing Liquidity Spiral, Nuvama Warns

The Quick Take

• BSE's Closing Auction Session has drawn criticism from Nuvama after participation rates collapsed, causing option premium volumes to fall sharply in a self-reinforcing liquidity spiral.
• Thin CAS liquidity creates perverse incentives: low volume leads to wide spreads, which drives away additional participants, compounding the dysfunction with each session.
• Alleged manipulation of the CAS closing-price mechanism and retail investor concerns have intensified regulatory scrutiny of BSE's new closing methodology.

BSE's Closing Auction Session was designed to improve price discovery at the close of trading by aggregating buy and sell orders before setting the official closing price. The mechanism mirrors implementations in European exchanges and should theoretically reduce end-of-day volatility and manipulation. However, the BSE rollout has encountered a structural participation problem: without critical mass of simultaneous bidders, the CAS produces thin price discovery that is arguably worse than the methodology it replaced, undermining its core rationale and creating the very uncertainty it was designed to eliminate.

Nuvama's analysis quantifies the damage in the derivatives market, where option premium volumes and contracts outstanding have declined sharply since CAS implementation. The mechanism matters for options because the CAS-set closing price is used to settle daily mark-to-market and calculate settlement values. Poorly discovered closing prices introduce settlement risk that sophisticated market participants price into wider bid-ask spreads, directly impairing the utility of BSE index derivatives as hedging instruments for institutional portfolio managers.

The allegations of CAS manipulation are particularly serious because thin-liquidity environments can enable a small number of participants to influence the officially recognised closing price for a significant portion of listed equities. SEBI's oversight posture will be critical: if regulators conclude BSE's CAS design is structurally flawed, a suspension or material redesign could trigger temporary settlement uncertainty. Nuvama's prescription—requiring higher participation thresholds before CAS prices are accepted as official—would require close cooperation between BSE and SEBI on revised technical specifications.

Synthesized from 1 source.